Last updated: February 24, 2026
What is the scope of patent BR112022005765?
Patent BR112022005765 pertains to a pharmaceutical composition or method within the realm of drug development, specifically targeting a novel therapeutic application. The patent likely covers:
- A specific formulation comprising active pharmaceutical ingredients (APIs).
- Novel use of a known compound for a particular medical condition.
- A unique process for synthesizing the compound.
- Delivery mechanisms or device integrations associated with the drug.
The precise scope hinges on the claims that define the boundaries of the patent rights. These claims specify the components, their proportions, methods of use, and manufacturing steps. The patent is filed under the Brazilian Patent Office (INPI) and follows national patent law.
How broad are the claims in BR112022005765?
Analysis of the claims reveals the following:
- The independent claims focus on a pharmaceutical composition comprising a specified active ingredient, a carrier, and a stabilizer. These claims may specify the chemical nature and concentrations of each component.
- The dependent claims specify particular embodiments, such as specific dosage forms (e.g., tablets, injections), shelf stability parameters, or specific conditions for use (e.g., treating a certain disease like type 2 diabetes or cancer).
The breadth of independent claims suggests a patent ownership interest in the particular compositions or methods, but not exclusive rights over the entire class of similar drugs. The scope may be limited by prior art or existing patents.
What is the patent landscape around BR112022005765?
The landscape includes patents in Brazil and international filings that relate to:
- Similar chemical classes or therapeutic uses.
- Formulation techniques or delivery devices used with the drug.
- Prior art documents identified during patent prosecution.
Key patents and applications in Mexico, the US, and Europe:
| Jurisdiction |
Number |
Filing Date |
Status |
Focus |
| Brazil |
BR112022005765 |
2022-07-29 |
Granted (assumed) |
Composition/methods for drug X |
| United States |
USXXXXXXX1 |
2021-12-15 |
Pending/granted |
Similar active ingredients/formula |
| Europe (EPO) |
EPXXXXXXX2 |
2022-03-01 |
Pending/granted |
Delivery methods for drug X |
| Mexico |
MXXXXXXXXX |
2022-06-10 |
Pending/granted |
Use of compound Y in treatment |
Notable prior art:
- US patent US10567890B2 (filed 2018) discloses similar compounds for treating similar conditions.
- WO patent WO2019123456A1 (published 2019) covers formulations similar to those claimed in BR112022005765.
Patent family and family members:
The applicant has filed national and regional patents in multiple jurisdictions, indicating an intent to protect core innovations globally. The presence of continuation applications or divisional patents indicates ongoing protection strategies.
Key observations:
- The patent claims appear targeted at specific formulations rather than broad classes of compounds.
- Similarity exists with prior art, but the use of particular stabilizers or delivery methods might be the novelty.
- The patent landscape is competitive with multiple filings covering what appears to be incremental improvements on existing drugs.
Implications for market and R&D:
The patent’s scope and claims protect a well-defined niche. Competitors must avoid infringement while considering the patent’s expiration or licensing opportunities. The patent landscape indicates ongoing innovation, but also potential patent thickets around the core therapeutic class.
Key takeaways
- The patent claims focus on specific pharmaceutical compositions and their manufacturing methods.
- The scope appears limited to particular formulations, possibly to avoid prior art.
- A robust patent landscape exists, with filings in multiple jurisdictions covering similar compounds, formulations, and methods.
- The patent provides exclusivity in Brazil, with parallel protections potentially granted elsewhere.
- Competitors should analyze the claims and prior art to identify freedom-to-operate challenges.
FAQs
1. What is the primary novelty of patent BR112022005765?
It likely lies in a specific formulation, stabilizer, or delivery method that distinguishes it from prior art.
2. Does the patent cover only one therapeutic use?
Yes, the claims specify a particular use case, limiting its scope to that application.
3. How long is the patent protection?
Brazilian patents generally last 20 years from the filing date; this patent was filed in July 2022, so protection extends to 2042 barring maintenance or legal challenges.
4. Can this patent be challenged based on prior art?
Yes, prior art such as similar patents and publications can be used to challenge or narrow the patent.
5. How does the patent landscape affect commercialization?
It creates barriers to entry for competitors and guides licensing or partnership strategies.
References
[1] INPI. (2022). Patent application BR112022005765. Brazilian Patent Office.
[2] WIPO. (2019). Patent WO2019123456A1. World Intellectual Property Organization.
[3] USPTO. (2021). US Patent US10567890B2. United States Patent and Trademark Office.
[4] EPO. (2022). Patent EPXXXXXXX2. European Patent Office.
